Clinical trials
Lymphoma, T-Cell, Cutaneous trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| No longer available | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| 4SC AG | 2 |
| Eisai Inc. | 2 |
| Kyowa Kirin, Inc. | 2 |
| University College, London | 2 |
| BioCryst Pharmaceuticals | 1 |
| Cancer Research Campaign Clinical Trials Centre | 1 |
| Cancer Research UK | 1 |
| Celgene | 1 |
| Clatterbridge Centre for Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Cutaneous | 25 |
| Mycosis Fungoides | 15 |
| Sezary Syndrome | 13 |
| Lymphoma | 12 |
| Lymphoma, Non-Hodgkin | 7 |
| Hodgkin Disease | 6 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Burkitt Lymphoma | 4 |
| Intraocular Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.